Stock Taper
Global Health Solutions, Inc. (Turn Therapeutics) develops skin, nail, and eye drugs using advanced delivery tech to treat wounds and skin conditions while reducing antibiotic resistance, based in Westlake Village, CA since 2015.

Turn Therapeutics' primary focus is a Phase 2 non-steroidal topical treatment for moderate-to-severe atopic dermatitis, utilizing proprietary PermaFusion® technology to modulate skin immune response.
Overall rating: C-
| PEER | PRICE | |
|---|---|---|
AGEN | $7.66 | COMPARE |
IKT | $2.41 | COMPARE |
IRD | $3.69 | COMPARE |
GLSI | $15.67 | COMPARE |
HURA | $2.11 | COMPARE |
ANIX | $3.48 | COMPARE |
SEER | $1.98 | COMPARE |
CGTX | $1.02 | COMPARE |